- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-1-1-1-3-3-3-1-1-1-9-1-1-1-1-1-mer
- Ligands
- 1 x BGC- GAL- NGA- GAL- SIA: beta-D-galactopyranose-(1-3)-2-acetamido-2-deoxy-beta-D-galactopyranose-(1-4)-[N-acetyl-alpha-neuraminic acid-(2-3)]beta-D-galactopyranose-(1-4)-beta-D-glucopyranose
- 1 x GAL- NGA- GAL- SIA: beta-D-galactopyranose-(1-3)-2-acetamido-2-deoxy-beta-D-galactopyranose-(1-4)-[N-acetyl-alpha-neuraminic acid-(2-3)]beta-D-galactopyranose
- 5 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.3: 4 residues within 4Å:- Chain 7: Y.278, F.317, T.319, N.350
No protein-ligand interaction detected (PLIP)NAG-NAG.4: 4 residues within 4Å:- Chain 7: S.259, N.261, E.410
- Chain 8: Y.293
2 PLIP interactions:2 interactions with chain 7- Hydrogen bonds: 7:E.410, 7:E.410
NAG-NAG.5: 3 residues within 4Å:- Chain 7: F.301, N.303, F.306
No protein-ligand interaction detected (PLIP)NAG-NAG.6: 3 residues within 4Å:- Chain 7: N.273, D.284, T.286
No protein-ligand interaction detected (PLIP)NAG-NAG.7: 5 residues within 4Å:- Chain 5: N.70
- Chain 6: E.87
- Chain I: L.494, R.495, N.497
No protein-ligand interaction detected (PLIP)- 1 x NAG- NAG- BMA- MAN- MAN- MAN- GLC- GLC- GLC- MAN- MAN: alpha-D-glucopyranose-(1-2)-alpha-D-glucopyranose-(1-3)-alpha-D-glucopyranose-(1-3)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN-MAN-GLC-GLC-GLC-MAN-MAN.8: 20 residues within 4Å:- Chain 5: L.63, F.64
- Chain I: M.484, E.492, T.493, G.496, N.497, Q.501, L.502, N.503, A.505, S.534, K.593, S.602, E.603, N.604, A.605, P.606
- Ligands: NAG.14, WJP.15
1 PLIP interactions:1 interactions with chain I- Hydrogen bonds: I:S.602, I:E.603, I:E.492, I:T.493, I:N.604
- 4 x CLR: CHOLESTEROL(Non-covalent)
CLR.9: 7 residues within 4Å:- Chain I: F.370, Y.448, L.451, L.452, F.456, Y.459
- Ligands: PTY.12
7 PLIP interactions:7 interactions with chain I- Hydrophobic interactions: I:F.370, I:F.370, I:Y.448, I:L.451, I:L.452, I:F.456, I:Y.459
CLR.20: 7 residues within 4Å:- Chain 7: F.421
- Chain 8: Y.303
- Chain U: C.18
- Ligands: WSS.17, WSS.18, WSS.26, WSS.39
1 PLIP interactions:1 interactions with chain 7- Hydrophobic interactions: 7:F.421
CLR.28: 5 residues within 4Å:- Chain Z: L.104, F.108
- Ligands: PTY.29, CLR.40, PTY.41
2 PLIP interactions:2 interactions with chain Z- Hydrophobic interactions: Z:L.104, Z:F.108
CLR.40: 6 residues within 4Å:- Chain 8: I.322
- Ligands: WSS.21, PTY.22, CLR.28, PTY.29, PTY.41
2 PLIP interactions:2 interactions with chain 8- Hydrophobic interactions: 8:I.322, 8:I.322
- 1 x PSF: 1,2-DICAPROYL-SN-PHOSPHATIDYL-L-SERINE(Non-covalent)
- 13 x PTY: PHOSPHATIDYLETHANOLAMINE(Non-covalent)
PTY.11: 7 residues within 4Å:- Chain 5: G.35, T.39, T.43
- Chain I: E.3, I.546, H.547, F.550
2 PLIP interactions:2 interactions with chain I- Hydrophobic interactions: I:I.546, I:F.550
PTY.12: 8 residues within 4Å:- Chain 5: N.33, M.40, L.41, C.44
- Chain I: N.368, K.369, F.370
- Ligands: CLR.9
6 PLIP interactions:3 interactions with chain 5, 3 interactions with chain I- Hydrophobic interactions: 5:M.40, 5:L.41, I:F.370
- Hydrogen bonds: 5:N.33, I:N.368, I:K.369
PTY.22: 3 residues within 4Å:- Chain U: L.6, V.13
- Ligands: CLR.40
No protein-ligand interaction detected (PLIP)PTY.23: 12 residues within 4Å:- Chain 3: M.17, S.20, A.21, L.28
- Chain 4: L.7
- Chain 7: F.435
- Chain U: W.67, L.146, L.149, F.150
- Ligands: PTY.34, PTY.37
4 PLIP interactions:2 interactions with chain 3, 1 interactions with chain 7, 1 interactions with chain U- Hydrophobic interactions: 3:M.17, 3:A.21, 7:F.435, U:F.150
PTY.25: 12 residues within 4Å:- Chain 7: M.436, L.437, F.440
- Chain W: F.25, L.28, Y.32, A.35, K.36, L.101
- Chain X: F.108, A.109
- Ligands: WJS.27
3 PLIP interactions:3 interactions with chain W- Hydrophobic interactions: W:F.25, W:F.25, W:L.101
PTY.29: 6 residues within 4Å:- Chain Z: F.25, Y.32, A.35
- Ligands: CLR.28, PTY.30, CLR.40
2 PLIP interactions:2 interactions with chain Z- Hydrophobic interactions: Z:F.25, Z:F.25
PTY.30: 5 residues within 4Å:- Chain 0: Y.32, F.108, I.112
- Ligands: PTY.29, PTY.31
1 PLIP interactions:1 interactions with chain 0- Hydrogen bonds: 0:Y.32
PTY.31: 8 residues within 4Å:- Chain 0: M.17, L.28, Y.32, F.108
- Chain 1: L.104, F.108
- Ligands: PTY.30, PTY.32
3 PLIP interactions:2 interactions with chain 0, 1 interactions with chain 1- Hydrogen bonds: 0:Y.32, 0:Y.32
- Hydrophobic interactions: 1:L.104
PTY.32: 13 residues within 4Å:- Chain 1: M.17, V.24, L.28, Y.32, A.35, K.36, F.108
- Chain 2: L.101, L.104, F.108, A.109
- Ligands: PTY.31, PTY.33
4 PLIP interactions:2 interactions with chain 1, 2 interactions with chain 2- Hydrophobic interactions: 1:L.28, 1:F.108, 2:L.101, 2:L.104
PTY.33: 8 residues within 4Å:- Chain 2: A.31, Y.32, A.35, K.36, F.108
- Chain 3: F.108
- Chain 4: F.3
- Ligands: PTY.32
5 PLIP interactions:2 interactions with chain 2, 3 interactions with chain 3- Hydrophobic interactions: 2:A.35, 2:F.108, 3:F.108, 3:F.108, 3:F.108
PTY.34: 5 residues within 4Å:- Chain 4: Y.8
- Chain 7: H.445
- Chain U: T.2
- Ligands: PTY.23, PTY.37
3 PLIP interactions:1 interactions with chain U, 2 interactions with chain 7- Hydrogen bonds: U:T.2
- Salt bridges: 7:H.445, 7:H.445
PTY.37: 10 residues within 4Å:- Chain 4: L.7
- Chain 7: F.435, F.438, I.439, T.441, Y.442, H.445
- Chain U: W.67
- Ligands: PTY.23, PTY.34
9 PLIP interactions:8 interactions with chain 7, 1 interactions with chain 4- Hydrophobic interactions: 7:F.435, 7:F.438, 7:F.438, 7:F.438, 7:I.439, 7:T.441, 7:Y.442
- Salt bridges: 7:H.445
- Hydrogen bonds: 4:L.7
PTY.41: 9 residues within 4Å:- Chain 8: V.321, S.325, Y.326, W.329, N.330
- Chain Y: F.25, L.97
- Ligands: CLR.28, CLR.40
4 PLIP interactions:2 interactions with chain Y, 2 interactions with chain 8- Hydrophobic interactions: Y:F.25, Y:L.97, 8:V.321
- Hydrogen bonds: 8:N.330
- 10 x WSS: tri(methyl)-[2-[[(2~{R})-2-[(~{Z})-octadec-9-enoyl]oxy-3-[(~{E})-1-oxidanylideneoctadec-9-enoxy]propoxy]-oxidanyl-phosphoryl]oxyethyl]azanium(Covalent)(Non-covalent)
WSS.13: 15 residues within 4Å:- Chain 5: H.79, W.80
- Chain 6: W.60, I.63, M.67, L.68, F.71, H.75, S.76, V.78
- Chain I: L.415, L.418, L.472, N.473, I.474
9 PLIP interactions:3 interactions with chain I, 5 interactions with chain 6, 1 interactions with chain 5- Hydrophobic interactions: I:L.415, I:L.418, I:L.472, 6:L.68, 6:F.71, 6:F.71
- Hydrogen bonds: 6:S.76, 6:A.77
- Salt bridges: 5:H.79
WSS.17: 15 residues within 4Å:- Chain 7: A.419, F.421
- Chain 8: Y.299, Y.303, F.307
- Chain U: F.15, A.21, V.22, C.25, Y.26, F.29, L.31, R.34
- Ligands: WSS.18, CLR.20
7 PLIP interactions:4 interactions with chain U, 3 interactions with chain 8- Hydrophobic interactions: U:F.15, U:V.22, U:Y.26, U:F.29, 8:F.307
- pi-Cation interactions: 8:Y.299, 8:Y.303
WSS.18: 12 residues within 4Å:- Chain 0: Y.10, F.14, F.90
- Chain 7: Y.414
- Chain U: C.25, F.29, D.30, L.31
- Chain Z: Y.10
- Ligands: WSS.17, CLR.20, WSS.39
6 PLIP interactions:3 interactions with chain 0, 1 interactions with chain Z, 1 interactions with chain 7, 1 interactions with chain U- Hydrophobic interactions: 0:F.14, 0:F.90, Z:Y.10, U:F.29
- Hydrogen bonds: 0:Y.10
- pi-Cation interactions: 7:Y.414
WSS.19: 10 residues within 4Å:- Chain 7: S.420, F.421, F.422, W.427
- Chain U: V.22, Y.26, R.34, F.35, D.36, W.39
6 PLIP interactions:4 interactions with chain U, 2 interactions with chain 7- Hydrogen bonds: U:D.36, 7:F.421, 7:F.422
- Salt bridges: U:R.34
- pi-Cation interactions: U:W.39, U:W.39
WSS.21: 8 residues within 4Å:- Chain 8: I.323, Y.326, N.327
- Chain U: T.2, G.3, L.6, G.10
- Ligands: CLR.40
6 PLIP interactions:4 interactions with chain 8, 2 interactions with chain U- Hydrophobic interactions: 8:I.323, 8:I.323, 8:Y.326, U:L.6
- Hydrogen bonds: 8:N.327, U:G.3
WSS.24: 14 residues within 4Å:- Chain 7: S.423, G.425, I.426, G.429, S.433
- Chain 8: F.301, S.304, V.305, N.308, W.312, I.313
- Chain V: Y.10
- Chain W: Y.10, F.14
5 PLIP interactions:2 interactions with chain 8, 1 interactions with chain W, 2 interactions with chain 7- Hydrophobic interactions: 8:W.312, 8:I.313
- Hydrogen bonds: W:Y.10, 7:S.423, 7:G.425
WSS.26: 13 residues within 4Å:- Chain 8: K.298, N.300, Y.303, F.307, V.310
- Chain X: E.9, Y.10, F.13
- Chain Y: Y.10, L.86, F.90
- Ligands: CLR.20, WSS.39
6 PLIP interactions:4 interactions with chain 8, 1 interactions with chain X, 1 interactions with chain Y- Hydrophobic interactions: 8:Y.303, 8:F.307, 8:V.310, X:F.13, Y:F.90
- Hydrogen bonds: 8:N.300
WSS.35: 15 residues within 4Å:- Chain 2: Y.10
- Chain 3: Y.10, F.14, F.90
- Chain 7: Y.332, V.334, S.335, W.339, T.362
- Chain U: G.32, F.35, D.36, V.37, A.38
- Ligands: WSS.36
7 PLIP interactions:2 interactions with chain U, 1 interactions with chain 7, 3 interactions with chain 3, 1 interactions with chain 2- Hydrogen bonds: U:V.37, U:A.38
- pi-Cation interactions: 7:Y.332
- Hydrophobic interactions: 3:F.14, 3:F.14, 3:F.90, 2:Y.10
WSS.36: 13 residues within 4Å:- Chain 1: Y.10
- Chain 2: P.8, Y.10, F.14, L.86, F.90
- Chain 7: S.335, R.337
- Chain U: A.19, G.23, G.32, F.35
- Ligands: WSS.35
6 PLIP interactions:1 interactions with chain U, 3 interactions with chain 2, 1 interactions with chain 1, 1 interactions with chain 7- Hydrophobic interactions: U:F.35, 2:F.14, 2:F.90
- Hydrogen bonds: 2:Y.10
- Salt bridges: 1:E.9, 7:R.337
WSS.39: 9 residues within 4Å:- Chain 8: Y.297, Y.299, Y.303
- Chain Y: Y.10, F.14
- Chain Z: L.93
- Ligands: WSS.18, CLR.20, WSS.26
4 PLIP interactions:2 interactions with chain 8, 1 interactions with chain Z, 1 interactions with chain Y- Hydrogen bonds: 8:Y.297, Y:Y.10
- pi-Cation interactions: 8:Y.297
- Hydrophobic interactions: Z:L.93
- 2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x WJP: methyl (3R,6Z,10E,14E)-3,7,11,15,19-pentamethylicosa-6,10,14,18-tetraen-1-yl dihydrogen diphosphate(Non-covalent)
WJP.15: 17 residues within 4Å:- Chain I: S.534, M.537, K.538, V.541, F.583, K.593, S.607, L.608, L.609, F.612, F.616, I.732, T.735, A.736
- Chain X: V.71
- Chain Y: I.147
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN-GLC-GLC-GLC-MAN-MAN.8
16 PLIP interactions:14 interactions with chain I, 1 interactions with chain X, 1 interactions with chain Y- Hydrophobic interactions: I:V.541, I:F.583, I:L.609, I:F.612, I:F.616, I:F.616, I:T.735, I:A.736, X:V.71, Y:I.147
- Hydrogen bonds: I:L.608, I:L.609
- Salt bridges: I:K.538, I:K.538, I:K.593, I:K.593
- 1 x ADP: ADENOSINE-5'-DIPHOSPHATE(Non-covalent)
ADP.16: 15 residues within 4Å:- Chain L: A.251, G.253, C.254, G.255, K.256, T.257, V.258, E.283, F.445, Q.522, N.523, G.524, Y.525
- Chain O: R.400, K.403
13 PLIP interactions:11 interactions with chain L, 2 interactions with chain O- Hydrogen bonds: L:A.251, L:G.253, L:C.254, L:G.255, L:K.256, L:T.257, L:V.258, L:Q.522, L:G.524
- Salt bridges: L:K.256, O:R.400, O:R.400
- pi-Stacking: L:F.445
- 1 x WJS: (2~{S})-2-$l^{4}-azanyl-3-[[(2~{R})-3-octadecanoyloxy-2-oxidanyl-propoxy]-oxidanyl-oxidanylidene-$l^{6}-phosphanyl]oxy-propanoic acid(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wang, L. et al., Structures of a Complete Human V-ATPase Reveal Mechanisms of Its Assembly. Mol.Cell (2020)
- Release Date
- 2020-11-11
- Peptides
- V-type proton ATPase subunit E 1: ABC
V-type proton ATPase subunit G 1: DEF
V-type proton ATPase subunit C 1: G
V-type proton ATPase subunit H: H
V-type proton ATPase 116 kDa subunit a isoform 1: I
V-type proton ATPase catalytic subunit A: JKL
V-type proton ATPase subunit B, brain isoform: MNO
SidK: PQR
V-type proton ATPase subunit D: S
V-type proton ATPase subunit F: T
V-type proton ATPase 21 kDa proteolipid subunit: U
V-type proton ATPase 16 kDa proteolipid subunit: VWXYZ0123
V-type proton ATPase subunit d 1: 4
V-type proton ATPase subunit e 1: 5
Ribonuclease kappa: 6
V-type proton ATPase subunit S1: 7
Renin receptor: 8 - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
HB
IC
JD
KE
LF
MG
OH
PI
RJ
AK
BL
CM
DN
EO
FP
XQ
YR
ZS
GT
NU
0V
1W
2X
3Y
4Z
50
61
72
83
94
Q5
S6
T7
U8
V - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-1-1-1-3-3-3-1-1-1-9-1-1-1-1-1-mer
- Ligands
- 1 x BGC- GAL- NGA- GAL- SIA: beta-D-galactopyranose-(1-3)-2-acetamido-2-deoxy-beta-D-galactopyranose-(1-4)-[N-acetyl-alpha-neuraminic acid-(2-3)]beta-D-galactopyranose-(1-4)-beta-D-glucopyranose
- 1 x GAL- NGA- GAL- SIA: beta-D-galactopyranose-(1-3)-2-acetamido-2-deoxy-beta-D-galactopyranose-(1-4)-[N-acetyl-alpha-neuraminic acid-(2-3)]beta-D-galactopyranose
- 5 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x NAG- NAG- BMA- MAN- MAN- MAN- GLC- GLC- GLC- MAN- MAN: alpha-D-glucopyranose-(1-2)-alpha-D-glucopyranose-(1-3)-alpha-D-glucopyranose-(1-3)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x CLR: CHOLESTEROL(Non-covalent)
- 1 x PSF: 1,2-DICAPROYL-SN-PHOSPHATIDYL-L-SERINE(Non-covalent)
- 13 x PTY: PHOSPHATIDYLETHANOLAMINE(Non-covalent)
- 10 x WSS: tri(methyl)-[2-[[(2~{R})-2-[(~{Z})-octadec-9-enoyl]oxy-3-[(~{E})-1-oxidanylideneoctadec-9-enoxy]propoxy]-oxidanyl-phosphoryl]oxyethyl]azanium(Covalent)(Non-covalent)
- 2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x WJP: methyl (3R,6Z,10E,14E)-3,7,11,15,19-pentamethylicosa-6,10,14,18-tetraen-1-yl dihydrogen diphosphate(Non-covalent)
- 1 x ADP: ADENOSINE-5'-DIPHOSPHATE(Non-covalent)
- 1 x WJS: (2~{S})-2-$l^{4}-azanyl-3-[[(2~{R})-3-octadecanoyloxy-2-oxidanyl-propoxy]-oxidanyl-oxidanylidene-$l^{6}-phosphanyl]oxy-propanoic acid(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wang, L. et al., Structures of a Complete Human V-ATPase Reveal Mechanisms of Its Assembly. Mol.Cell (2020)
- Release Date
- 2020-11-11
- Peptides
- V-type proton ATPase subunit E 1: ABC
V-type proton ATPase subunit G 1: DEF
V-type proton ATPase subunit C 1: G
V-type proton ATPase subunit H: H
V-type proton ATPase 116 kDa subunit a isoform 1: I
V-type proton ATPase catalytic subunit A: JKL
V-type proton ATPase subunit B, brain isoform: MNO
SidK: PQR
V-type proton ATPase subunit D: S
V-type proton ATPase subunit F: T
V-type proton ATPase 21 kDa proteolipid subunit: U
V-type proton ATPase 16 kDa proteolipid subunit: VWXYZ0123
V-type proton ATPase subunit d 1: 4
V-type proton ATPase subunit e 1: 5
Ribonuclease kappa: 6
V-type proton ATPase subunit S1: 7
Renin receptor: 8 - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
HB
IC
JD
KE
LF
MG
OH
PI
RJ
AK
BL
CM
DN
EO
FP
XQ
YR
ZS
GT
NU
0V
1W
2X
3Y
4Z
50
61
72
83
94
Q5
S6
T7
U8
V - Membrane
-
We predict this structure to be a membrane protein.